Advertisement
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of April 6 to 10

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Stomach acid suppression medications increase the odds of intestinal colonization with multidrug-resistant microorganisms

Suppressing Stomach Acid May Up Intestinal Growth of MDROs

0
Gastric acid suppression increased odds of intestinal colonization with MDROs by about 75 percent
One dose of convalescent plasma therapy is well tolerated and can potentially improve clinical symptoms in severe cases with coronavirus disease 2019

Convalescent Plasma Treatment Promising in Severe COVID-19

0
One dose of CP with neutralizing antibodies can reduce viral load, tends to improve clinical symptoms
Researchers have identified the most common clinical characteristics among 109 patients out of 1

Older Adults, Men, Preexisting Conditions Tied to COVID-19 Death

0
Patients admitted to ICU lived longer, but bed shortages in Wuhan prevented admission for all who needed it
Another clinical trial of an experimental vaccine for the novel coronavirus 2019 has been launched by U.S. researchers.

Another COVID-19 Vaccine Trial Begins in the United States

0
Experimental vaccine is given using a skin-deep shot instead of the typical deeper jab
A clinical trial to assess the antimalarial drug hydroxychloroquine as a treatment for adults with the novel coronavirus is now underway

NIH Launches Clinical Trial of Hydroxychloroquine for COVID-19

0
Enrollees include more than 500 adults hospitalized or expected to be hospitalized with COVID-19
The novel coronavirus has been circulating in New York City for longer than previously believed and most cases can be traced back to Europe

COVID-19 Came to New York City From Europe, Not Asia

0
Specific genetic codes in most New York City viral samples indicate they originated in Europe
Doctors at the University of Alabama at Birmingham are enrolling patients in an international clinical trial to find out if inhaled nitric oxide benefits those with novel coronavirus who have severely damaged lungs.

Clinical Trial Underway to Test Nitric Oxide in COVID-19 Patients

0
Nitric oxide can improve blood flow in areas of the lungs still receiving air, may have antiviral properties
A report issued by the U.S. Department of Health and Human Services Office of Inspector General provides a national snapshot of hospital experiences in response to the coronavirus disease 2019.

HHS Report Looks at Hospital Experiences With COVID-19

0
Most significant challenges relate to testing and caring for COVID-19 patients, keeping staff safe
From 2012 to 2017

Some Multidrug-Resistant Bacterial Infections Down in U.S.

0
MRSA, vancomycin-resistant enterococcal, MDR P. aeruginosa infection rates fell from 2012 to 2017